Clinical Trials Logo

Complication of Treatment clinical trials

View clinical trials related to Complication of Treatment.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06301048 Completed - Clinical trials for Complication of Treatment

Effectiveness of Endoscopic Papillectomy With Stent for Treating Duodenal Papillary Adenoma

Start date: November 7, 2023
Phase:
Study type: Observational

This is a retrospective study, including 79 patients with duodenal papillary adenoma, who treated with Endoscopic Papillectomy (EP) at Beijing friendship hospital. The cohort included patients who underwent EP with or without Pancreatic Duct (PD) and Common Bile Duct (CBD) stent placement. The investigators assessed the outcomes of EP and the impact of stent placement on complications and recurrence rates.

NCT ID: NCT05903326 Completed - Effect of Drug Clinical Trials

Dexmedetomidine as a Sole Premedication for BMT Placement

BMT
Start date: February 11, 2022
Phase:
Study type: Observational

There is very little evidence or research documenting any single method of sedation/analgesia for myringotomy tube (BMT) placement as being more effective than others. This was a retrospective chart review conducted to determine if there were significant differences in efficacy of administered pre-operative Midazolam and Intraoperative IM Ketorolac (traditional) vs. pre-operative Dexmedetomidine alone for pain and emergence delirium management of children undergoing placement of BMTs. The current protocol was changed under the direction of anesthesia and team members who wanted to see what the outcomes of the new management plan were. The plan was a prospective chart review and for this project, 276 patient charts were reviewed, 154 patients received traditional anesthesia treatment and 122 received Precedex. Data analysis indicated that the patients who had received Dexmedetomidine had significantly higher FLACC scores (meaning better pain control) than those who received the traditional therapy. There was no difference in emergence delirium between the two groups.

NCT ID: NCT05892367 Completed - Clinical trials for Complication of Treatment

Transbrachial Access for Interventions in Patients With Peripheral Arterial Occlusive Disease

TBA
Start date: July 10, 2018
Phase: N/A
Study type: Interventional

The aim of the present study is an evaluation, whether an immobilization of the upper extremity by means of a positioning splint can help to reduce the incidence of local complications after transbrachial puncture for peripheral arterial interventions, or not.

NCT ID: NCT05238506 Completed - Acute Appendicitis Clinical Trials

Lidocaine VS Hemodynamic, Metabolic and Hormonal Response

Start date: March 12, 2022
Phase: Phase 4
Study type: Interventional

Intravenous lidocaine - a potent local anesthetic with analgesic and anti- inflammatory properties has been shown to be an effective adjunct that reduces intra and postoperative opioid consumption and facilitates pain management in adults. In children population promising but limited evidence is available. The study has been planned to evaluate the efficacy of continuous intravenous infusion of lidocaine in alleviation of hemodynamic reaction to tracheal intubation, as well as metabolic and hormonal response to laparoscopic procedure in children.

NCT ID: NCT04432740 Completed - Clinical trials for Distal Radius Fracture

A Novel Splint Technique for Distal Radius Treatment

Start date: April 15, 2017
Phase: N/A
Study type: Interventional

There are many conservative treatment methods, including below arm cast, above arm cast, and sugar tong splint that aim to obtain maximum functional, clinical, and radiological results There are no clear indications with regard to the best treatment including conservative or surgical methods for the different fracture subtypes in distal radius fracture. The purpose of this prospective randomized study was to compare a new reverse sugar tong splint technique that does not immobilize the elbow with a below-arm cast, in terms of patient radiological and clinical outcomes and the ability to maintain fracture reduction.

NCT ID: NCT04411459 Completed - COVID-19 Clinical Trials

Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome

Start date: February 1, 2020
Phase:
Study type: Observational

This multicentric prospective clinical practice study aims at evaluating clinical factors associated with a prolonged invasive mechanical ventilation and other outcomes such as mortality and ICU length of stay in patients affected from COVID-19 related pneumonia and ARDS.

NCT ID: NCT04039360 Completed - Clinical trials for Complication of Treatment

SEMS Placement Followed by Chemotherapy and Surgery for Obstructing Left-sided Colonic Cancer

Start date: May 1, 2014
Phase:
Study type: Observational

This study aimed to evaluate the safety and feasibility of SEMS followed by neoadjuvant chemotherapy prior to elective surgery for obstructing left-sided colon cancer.

NCT ID: NCT03677765 Completed - Catheterization Clinical Trials

Comparisons of Complications Related to Two Approaches of Ultrasonography-guided Subclavian Venous Catheterization

Start date: November 27, 2018
Phase: N/A
Study type: Interventional

For performing subclavian venous catheterization, two approaches (supraclavicular and infraclavicular) have been used successfully in various clinical practice. However, there remains controversy concerning which approach is safer and causes less complications during ultrasonography-guided subclavian venous catheterization. In this context, the investigators sought to compare supraclavicular approach with infraclavicular approach in terms of post-procedural complications during ultrasonography-guided subclavian venous catheterization.

NCT ID: NCT03061370 Completed - Obesity Clinical Trials

Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer

Start date: January 1, 2010
Phase:
Study type: Observational

In line with improvements in oncologic outcome for patients with esophageal cancer, the attritional impact of curative treatment with respect to functional status and health-related quality of life (HR-QL) in survivorship is increasingly an important focus. Functional recovery after surgery for esophageal cancer is commonly confounded by anorexia and early satiety, which may reduce oral nutrient intake with consequent malnutrition and weight loss. One in three disease-free patients has more than fifteen percent body weight loss at three years after esophagectomy. The ESPEN Special Interest Group on cachexia-anorexia in chronic wasting diseases has defined sarcopenia as skeletal muscle index (SMI) of ≤39 cm2/m2 for women and ≤55cm2/m2 for men, while similar cut-off points have been validated in upper gastrointestinal and respiratory malignancies (less than 38.5 cm2/m2 for women and 52.4 cm2/m2 for men). The European Working Group on Sarcopenia in Older People (EWGSOP) additionally recommends that assessment should also include determination of muscle function, for example gait speed or grip strength, where possible. The presence of sarcopenia is associated with increase treatment-associated morbidity, impaired HR-QL, reduced physical and role functioning, and increased pain scores in older adults. In addition, a previous longitudinal study demonstrated that the decline in HR-QL over a six year period in older adults was accelerated in the presence of sarcopenia. As such, sarcopenia may represent a modifiable barrier to recovery and subsequent retention of HR-QL and functional status, and may reinforce a persistent illness identity, among patients following potentially curative treatment for esophageal cancer.